Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma.

Ren H, Zhao T, Sun J, Wang X, Liu J, Gao S, Yu M, Hao J.

J Cell Biochem. 2013 Nov;114(11):2603-11. doi: 10.1002/jcb.24608.

PMID:
23857671
2.

High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma.

Xu X, Wang Y, Chen J, Ma H, Shao Z, Chen H, Jin G.

J Gastrointest Surg. 2012 Aug;16(8):1493-8. doi: 10.1007/s11605-012-1921-7. Epub 2012 May 26.

PMID:
22639377
3.

Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.

Huang L, Ma B, Ma J, Wang F.

Biochem Biophys Res Commun. 2017 Dec 2;493(4):1510-1517. doi: 10.1016/j.bbrc.2017.10.006. Epub 2017 Oct 3.

PMID:
28986258
4.

Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.

Gan AM, Butoi ED, Manea A, Simion V, Stan D, Parvulescu MM, Calin M, Manduteanu I, Simionescu M.

Cell Tissue Res. 2013 Jan;351(1):161-74. doi: 10.1007/s00441-012-1510-9. Epub 2012 Oct 20.

PMID:
23086480
5.

Human cytomegalovirus chemokine receptor US28 induces migration of cells on a CX3CL1-presenting surface.

Hjortø GM, Kiilerich-Pedersen K, Selmeczi D, Kledal TN, Larsen NB.

J Gen Virol. 2013 May;94(Pt 5):1111-20. doi: 10.1099/vir.0.047290-0. Epub 2013 Jan 9.

PMID:
23303826
6.

Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.

Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J, Niizeki H, Kawamura Ki, Hosokawa M, Asaka M.

Cancer Res. 2001 Sep 1;61(17):6548-54.

7.

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Jöhrer K, Greil R, Trejo LE, Kharenko O, Feinmesser M, Yron I, Witz IP.

Cancer Lett. 2009 Jan 8;273(1):127-39. doi: 10.1016/j.canlet.2008.07.029. Epub 2008 Sep 7.

PMID:
18778890
8.

Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.

Marchesi F, Locatelli M, Solinas G, Erreni M, Allavena P, Mantovani A.

J Neuroimmunol. 2010 Jul 27;224(1-2):39-44. doi: 10.1016/j.jneuroim.2010.05.007. Epub 2010 Jul 13. Review.

PMID:
20630606
9.
10.

Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.

Wei LM, Cao S, Yu WD, Liu YL, Wang JT.

Oncol Rep. 2015 Feb;33(2):615-24. doi: 10.3892/or.2014.3645. Epub 2014 Dec 4.

PMID:
25482732
11.

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.

Celesti G, Di Caro G, Bianchi P, Grizzi F, Marchesi F, Basso G, Rahal D, Delconte G, Catalano M, Cappello P, Roncalli M, Zerbi A, Montorsi M, Novelli F, Mantovani A, Allavena P, Malesci A, Laghi L.

Br J Cancer. 2013 Oct 29;109(9):2424-33. doi: 10.1038/bjc.2013.565. Epub 2013 Oct 1.

12.

Hypoxia increases CX3CR1 expression via HIF-1 and NF‑κB in androgen-independent prostate cancer cells.

Xiao LJ, Chen YY, Lin P, Zou HF, Lin F, Zhao LN, Li D, Guo L, Tang JB, Zheng XL, Yu XG.

Int J Oncol. 2012 Nov;41(5):1827-36. doi: 10.3892/ijo.2012.1610. Epub 2012 Aug 27.

PMID:
22941344
13.

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.

Marchesi F, Piemonti L, Fedele G, Destro A, Roncalli M, Albarello L, Doglioni C, Anselmo A, Doni A, Bianchi P, Laghi L, Malesci A, Cervo L, Malosio M, Reni M, Zerbi A, Di Carlo V, Mantovani A, Allavena P.

Cancer Res. 2008 Nov 1;68(21):9060-9. doi: 10.1158/0008-5472.CAN-08-1810.

14.

Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments.

Wada A, Ito A, Iitsuka H, Tsuneyama K, Miyazono T, Murakami J, Shibahara N, Sakurai H, Saiki I, Nakayama T, Yoshie O, Koizumi K, Sugiyama T.

Oncol Rep. 2015 Jun;33(6):2935-9. doi: 10.3892/or.2015.3941. Epub 2015 Apr 28.

PMID:
25962684
15.

Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.

Zhao T, Gao S, Wang X, Liu J, Duan Y, Yuan Z, Sheng J, Li S, Wang F, Yu M, Ren H, Hao J.

PLoS One. 2012;7(8):e43399. doi: 10.1371/journal.pone.0043399. Epub 2012 Aug 27.

16.

CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema.

McComb JG, Ranganathan M, Liu XH, Pilewski JM, Ray P, Watkins SC, Choi AM, Lee JS.

Am J Pathol. 2008 Oct;173(4):949-61. doi: 10.2353/ajpath.2008.071034. Epub 2008 Sep 4.

17.

The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.

Green SR, Han KH, Chen Y, Almazan F, Charo IF, Miller YI, Quehenberger O.

J Immunol. 2006 Jun 15;176(12):7412-20.

18.

Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.

Büchler P, Reber HA, Büchler M, Shrinkante S, Büchler MW, Friess H, Semenza GL, Hines OJ.

Pancreas. 2003 Jan;26(1):56-64.

PMID:
12499918
19.

Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.

Schmall A, Al-Tamari HM, Herold S, Kampschulte M, Weigert A, Wietelmann A, Vipotnik N, Grimminger F, Seeger W, Pullamsetti SS, Savai R.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):437-47. doi: 10.1164/rccm.201406-1137OC.

PMID:
25536148
20.

Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.

Morimura S, Sugaya M, Sato S.

Am J Pathol. 2013 May;182(5):1640-7. doi: 10.1016/j.ajpath.2013.01.023. Epub 2013 Mar 5.

PMID:
23470165

Supplemental Content

Support Center